Development of LC-MS/MS methods affording identification and measurement of active metabolites in rat and dog plasma after oral dosing of a penta-ethyl ester prodrug of diethylenetriamine pentaacetic acid-Reference-Cited by-同舟云学术

Development of LC-MS/MS methods affording identification and measurement of active metabolites in rat and dog plasma after oral dosing of a penta-ethyl ester prodrug of diethylenetriamine pentaacetic acid

Published:2024-07-30 Issue:8 Volume:33 Page:1440-1449
ISSN:1054-2523
Container-title:Medicinal Chemistry Research
language:en
Short-container-title:Med Chem Res

Author:

Kagel John R.^ORCID,Jay Michael^ORCID,Zamboni William C.^ORCID

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00044-024-03264-6.pdf

Reference19 articles.

1. Singh VK, Romaine PLP, Seed TM. Medical countermeasures for radiation exposure and related injuries: characterization of medicines, FDA-approval status and inclusion into the strategic national stockpile. Health Phys. 2015;108:607–30. https://doi.org/10.1097/HP.0000000000000279.

2. FDA approves drugs to treat internal contamination from radioactive elements (2004) http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108339.htm. Accessed 30 May 2012.

3. U.S. Food and Drug Administration. Guidance for Industry. Internal Radioactive Contamination—Development of Decorporation Agents. 2006. http://www.fda.gov/CDER/guidance, Docket Number: FDA-2005-D-0025.

4. Stradling GN, Gray SA, Ellender M, Pearce M, Wilson I, Moody JC. et al. Removal of inhaled plutonium and americium from the rat by administration of ZnDTPA in drinking water. Hum Exp Toxicol. 1993;12:233–9. https://doi.org/10.1177/096032719301200306.

5. Spoor NL. The use of EDTA and DTPA for accelerating the removal of deposited transuranic elements from humans. 1977. Report NRPB-R59: National Radiological Protection Board, Harwell.